Arca Biopharma Stock
-
Your prediction
Arca Biopharma Stock
Pros and Cons of Arca Biopharma in the next few years
Pros
Cons
Performance of Arca Biopharma vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Arca Biopharma | - | - | - | - | - | - | - |
| Cellectar BioSciences Inc. | -6.420% | 6.250% | 57.143% | -87.935% | 19.872% | -90.685% | -96.438% |
| Beximco Pharmaceuticals Ltd. GDR | - | 6.132% | 12.500% | 6.635% | 8.696% | -49.153% | -1.316% |
| SELLAS Life Sciences Group Inc | 7.610% | -0.560% | 2.899% | 6.129% | 50.903% | -47.601% | -48.213% |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.The financials of ARCA Biopharma, Inc. (ABIO), a player in the pharmaceutical industry, provide a rather intriguing snapshot of a company in a challenging economic landscape. By examining the balance sheets, income statements, and cash flow statements, it becomes clear that ARCA is navigating through significant financial hurdles. The company is grappling with persistent losses, evidenced by negative net income figures over the past few years. However, there are also noteworthy aspects to consider, especially regarding asset management and liquidity.
Strong Cash Position: As of December 31, 2023, ARCA had a substantial cash reserve of $37,431,000. This liquidity is crucial for a pharmaceutical company, particularly in funding research and development activities, which are often costly and time-consuming. With a positive cash balance, ARCA has the ability to sustain operations and invest in future projects, which could yield returns in the long run.
Low Total Liabilities: The total liabilities stand at $841,000, which is remarkably low relative to the total assets of $37,861,000. This indicates a healthy equity position, as the company holds more assets than it owes, suggesting solid financial stability in terms of obligations.
Comments
